Metoclide 5 Injection contains Metoclopramide 5mg, a gastroprokinetic and antiemetic agent commonly used to treat nausea, vomiting, delayed gastric emptying, gastroparesis, and post-operative or chemotherapy-induced vomiting.
The injection works by stimulating gastrointestinal motility and blocking dopamine receptors in the central nervous system, providing rapid symptom relief. It is suitable for hospital and clinical use where oral administration is not feasible.
Metoclide 5 Injection belongs to the gastrointestinal and hospital injectable segment, frequently prescribed by gastroenterologists, general physicians, and oncologists.
For PCD pharma franchise partners, distributors, and exporters, Metoclide 5 Injection offers a profitable opportunity due to its high clinical demand and recurring hospital usage. It is available for bulk supply, monopoly-based franchise, third-party manufacturing, institutional distribution, and export.